References
Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395(10242):2008–2020. https://doi.org/10.1016/S0140-6736(20)30974-0
Allen PJ, Kuk D, Castillo CF et al (2017) Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients with Pancreatic Adenocarcinoma. Ann Surg. 265(1):185–191. https://doi.org/10.1097/SLA.0000000000001763
Tomasello G, Ghidini M, Costanzo A et al (2019) Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies. J Gastrointest Oncol 10(2):259–269. https://doi.org/10.21037/jgo.2018.12.08
Cannella R, Santinha J, Bèaufrere A et al (2023) Performances and variability of CT radiomics for the prediction of microvascular invasion and survival in patients with HCC: a matter of chance or standardisation? Eur Radiol. https://doi.org/10.1007/s00330-023-09852-1
Shi H, Chen Z, Dong S et al (2022) A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study. BMC Gastroenterol 22(1):279. https://doi.org/10.1186/s12876-022-02362-2
Li C, Ren Z, Han D et al (2020) A prognostic nomogram for pancreatic ductal adenocarcinoma patients’ all-cause survival in a Surveillance, Epidemiology, and End Results analysis. Transl Cancer Res 9(5):3586–3599. https://doi.org/10.21037/tcr-19-2962
Kim DW, Lee SS, Kim SO et al (2020) Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score. Radiology 296(3):541–551. https://doi.org/10.1148/radiol.2020200281
Xie T, Xie X, Liu W, Chen L, Liu K, Zhou Z (2023) Prediction of postoperative recurrence in resectable pancreatic body/tail adenocarcinoma: a novel risk stratification approach using a CT-based nomogram. Eur Radiol. https://doi.org/10.1007/s00330-023-10047-x
Hong SB, Lee SS, Kim JH et al (2018) Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria. Radiology 289(3):710–718. https://doi.org/10.1148/radiol.2018180628
Arrington AK, Hsu CH, Schaefer KL, O’Grady CL, Khreiss M, Riall TS (2021) Survival after Margin-Positive Resection in the Era of Modern Chemotherapy for Pancreatic Cancer: Do Patients Still Benefit? J Am Coll Surg 233(1):100–109. https://doi.org/10.1016/j.jamcollsurg.2021.02.020
Acknowledgements
The author thanks Dr. Marco Dioguardi Burgio.
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Giorgia Porrello.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was not required.
Ethical approval
Institutional Review Board approval was not required.
Study subjects or cohorts overlap
None
Methodology
• Commentary
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available at https://doi.org/10.1007/s00330-023-10047-x.
Rights and permissions
About this article
Cite this article
Porrello, G. Can a CT-based nomogram predict recurrence in resectable pancreatic body and tail adenocarcinoma?. Eur Radiol 33, 7779–7781 (2023). https://doi.org/10.1007/s00330-023-10193-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-023-10193-2